Is it safe for a 58‑year‑old woman with hypertension and prior stroke, already taking metoprolol tartrate 25 mg twice daily and lisinopril 20 mg twice daily, to double the lisinopril dose if her blood pressure remains uncontrolled?

Doubling Lisinopril is Reasonable but Not Optimal

In this 58-year-old woman with hypertension and prior stroke on metoprolol tartrate 25 mg twice daily and lisinopril 20 mg twice daily, doubling the lisinopril to 40 mg twice daily is safe and reasonable, but optimizing the current regimen or adding a third agent from a different class would be more guideline-concordant.

Current Regimen Assessment

This patient is already on two first-line antihypertensive agents from different classes (ACE inhibitor and beta-blocker), but both are at suboptimal doses:

• Lisinopril 20 mg twice daily (40 mg total daily): This is within the therapeutic range but can be increased. The FDA label indicates the usual dosage range is 20-40 mg per day in a single daily dose, with doses up to 80 mg studied 1.

• Metoprolol tartrate 25 mg twice daily (50 mg total daily): This is substantially below the effective dosage range of 100-450 mg per day for hypertension 2.

The Lisinopril Dosing Question

Safety of Doubling Lisinopril

Increasing lisinopril from 40 mg to 80 mg total daily dose is safe based on FDA labeling, which documents that doses up to 80 mg have been used 1. However, the label notes these higher doses "do not appear to give greater effect," suggesting diminishing returns beyond 40 mg daily.

Once Daily vs Twice Daily Dosing

The evidence on twice-daily vs once-daily lisinopril dosing is mixed but favors once-daily dosing:

• One small retrospective study (n=90) found twice-daily dosing produced greater systolic BP reduction (10.2 mmHg more) compared to the same total daily dose given once daily 3.

• However, a larger real-world study (n=11,210) found no difference in BP control between once-daily and twice-daily dosing, with absolute differences in systolic BP ranging from -1.8 to 0.7 mmHg 4. Importantly, this study found lisinopril 10 mg twice daily was associated with increased odds of angioedema (OR 2.27,95% CI 1.13-4.58) compared to 20 mg once daily 4.

The FDA label recommends once-daily dosing as the standard approach 1, and guidelines consistently support once-daily dosing to improve medication adherence 5.

Guideline-Concordant Approach

Step 1: Optimize Current Medications First

Before adding more lisinopril, increase the metoprolol dose, which is currently at only half the minimum effective dose:

• Increase metoprolol tartrate to 100 mg twice daily (the usual starting dose for hypertension) 2
• This can be titrated up to 200 mg twice daily if needed and tolerated
• Monitor for bradycardia and ensure heart rate remains >60 bpm

Step 2: Consider Adding a Third Agent

If BP remains uncontrolled after optimizing both current medications, add a third first-line agent rather than pushing lisinopril to supramaximal doses. The 2018 Hypertension Canada guidelines recommend adding agents from first-line choices when standard-dose dual therapy fails 6. The most evidence-based options are:

1. Thiazide or thiazide-like diuretic (e.g., hydrochlorothiazide 12.5-25 mg daily or chlorthalidone 12.5-25 mg daily) - Grade A recommendation 6
2. Long-acting dihydropyridine calcium channel blocker (e.g., amlodipine 5-10 mg daily) - Grade B recommendation 6

The combination of ACE inhibitor + beta-blocker + diuretic or ACE inhibitor + beta-blocker + CCB are both well-validated three-drug regimens 6, 7.

Step 3: If Doubling Lisinopril is Chosen

If the decision is made to increase lisinopril despite the above considerations:

• Convert to once-daily dosing: Give lisinopril 40 mg once daily rather than 20 mg twice daily (same total dose, better adherence) 5, 1
• If further increase needed: Advance to 80 mg once daily (maximum studied dose) 1
• Monitor closely for:
  • Hypotension (especially given prior stroke - avoid excessive BP drops) 8
  • Hyperkalemia (check potassium within 1-2 weeks)
  • Acute kidney injury (check creatinine)
  • Angioedema (higher risk with twice-daily dosing) 4

Special Considerations for Post-Stroke Patients

This patient's prior stroke history makes BP control particularly important but requires careful titration:

• Target BP for secondary stroke prevention: <140/90 mmHg per most guidelines 6, 9, though some suggest <130/80 mmHg for high-risk patients 10
• Avoid excessive BP lowering: Rapid or excessive BP reduction can compromise cerebral perfusion in patients with cerebrovascular disease 8
• ACE inhibitors are appropriate for stroke prevention and are recommended in patients with prior stroke 6, 7
• Beta-blockers, while not first-line for uncomplicated hypertension in patients >60 years, are reasonable in combination therapy and in patients with prior MI 6, 9

Common Pitfalls to Avoid

1. Don't push a single agent to maximum dose when dual therapy at standard doses hasn't been tried - The evidence shows combination therapy is more effective than monotherapy dose escalation 7, 5

2. Don't use twice-daily dosing without clear indication - It reduces adherence and may increase adverse events without improving efficacy 5, 4

3. Don't forget to check for secondary causes or poor adherence - Before intensifying therapy, verify medication adherence and consider secondary hypertension if BP remains uncontrolled on appropriate multi-drug therapy 6, 7

4. Don't combine ACE inhibitor with ARB - This combination increases adverse events without additional benefit and is explicitly not recommended (Grade A) 6, 9

Bottom Line Algorithm

1. First: Increase metoprolol tartrate to 100 mg twice daily
2. Second: If still uncontrolled, add hydrochlorothiazide 12.5-25 mg daily OR amlodipine 5-10 mg daily
3. Third: If still uncontrolled, consider increasing lisinopril to 80 mg once daily (not twice daily)
4. Fourth: If still uncontrolled on three agents, refer to hypertension specialist 10